Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-005919
Filing Date
2013-05-14
Accepted
2013-05-14 12:56:18
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gfrp_10q-033113.htm 10-Q 682751
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 20348
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 22574
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5665
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5681
  Complete submission text file 0001437749-13-005919.txt   4909587

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE gfrp-20130331.xml EX-101.INS 892072
7 XBRL TAXONOMY EXTENSION SCHEMA gfrp-20130331.xsd EX-101.SCH 39206
8 XBRL TAXONOMY EXTENSION CALCULATION gfrp-20130331_cal.xml EX-101.CAL 32435
9 XBRL TAXONOMY EXTENSION DEFINITION gfrp-20130331_def.xml EX-101.DEF 183994
10 XBRL TAXONOMY EXTENSION LABELS gfrp-20130331_lab.xml EX-101.LAB 249383
11 XBRL TAXONOMY EXTENSION PRESENTATION gfrp-20130331_pre.xml EX-101.PRE 188508
Mailing Address 9160 E. DEER TRAIL 9160 E. DEER TRAIL TUCSAN AZ 85710
Business Address SUITE 11405 - 201A STREET MAPLE RIDGE A1 V2X 0Y3 5205771516
GFR PHARMACEUTICALS INC (Filer) CIK: 0001096294 (see all company filings)

EIN.: 770517964 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27959 | Film No.: 13840381
SIC: 2834 Pharmaceutical Preparations